California-based Corinth MedTech, a urology healthcare company and the developer of the Veloxion System, has secured $12 million in Series D funding.
ShangBay Capital LLC and Aethan Capital, Inc. co-led the funding round, which saw participation from existing investors.
In connection with the funding round, ShangBay Capital will join the Corinth MedTech board of directors.
Corinth MedTech expects to use the new capital to launch the commercialization of the Veloxion System, which received U.S. Food and Drug Administration clearance in May 2019.